Creative Medical Technology Holdings, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Creative Medical Technology Holdings, Inc. (CELZ) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $1.84 million as of 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2020-05-15
- 2020-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.84M.
- 2019-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $6.85M.
- 2019-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.54M.
- 2019-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.38M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2020-03-31 | $1.84M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $6.85M 10-Q · filed 2020-05-15 |
| 2019-09-30 | $2.54M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.38M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.53M 10-Q · filed 2019-05-20 |
| 2018-12-31 | $3.23M 10-K · filed 2020-04-06 |
| 2018-09-30 | $6.82M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $9.93M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $7.05M 10-Q · filed 2018-08-03 |
| 2017-12-31 | $1.31M 10-K · filed 2019-04-01 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |